News Archives - Page 2 of 794

ThursdayJun 25, 2026 10:30 am

QualityStocksNewsBreaks –From Pilot to Scale: Manufacturing Partnerships and Commercialization in Service Robotics

TechForce Robotics has partnered with NUWA Robotics and Foxconn to support the transition from pilot deployments to scalable commercial production and enterprise rollout The company combines AI-driven robotics, enterprise automation infrastructure, and Robotics-as-a-Service capabilities to address growing demand for fleet-scale automation solutions Recent expansion into pharmaceutical automation broadens TechForce's addressable market while reinforcing its strategy of building a scalable robotics commercialization ecosystem TechForce Robotics, Inc. ("TechForce"), a subsidiary of Nightfood Holdings, Inc. (OTCQB: NGTF), is extending the boundaries of service robotics commercialization, moving its AI-powered automation platforms from pilot deployments into industrial-scale, revenue-generating fleet systems. Reputed for developing autonomous service…

ThursdayJun 25, 2026 9:45 am

Earth Science Tech Inc. (ETST) Presents Fiscal Year-End Financial Results for March 31, 2026, Operating a Diversified Holding Company Model

Earth Science Tech Inc. (OTC: ETST) recently reported year-end financial results for the fiscal year ending March 31, 2026 Earth Science Tech acquires, manages, and operates companies in pharmaceuticals, real estate, telemedicine, healthcare services, and other industries. Results include increases in revenue, gross profit, net income, and total assets. Earth Science Tech (OTC: ETST), a strategic holding company that acquires and manages a diverse portfolio of businesses, recently announced the financial results for the full fiscal year that ended on March 31, 2026 (https://ibn.fm/xRoIz). The reported results include: An 8% revenue increase compared to the year ended March 31, 2025,…

WednesdayJun 24, 2026 11:15 am

VERAXA Biotech AG (NASDAQ: VRXA) Advances BiTAC-ADC Platform as It Expands Next-Generation Cancer Therapy Pipeline

VERAXA Biotech has reported new in vitro proof-of-concept data supporting its BiTAC-ADC technology, demonstrating selective activity against cancer cells while sparing healthy cells in early testing. The company is presenting its BiTAC-ADC and BiTAC-TCE platforms for potential strategic collaborations at the BIO International Convention 2026. VERAXA’s proprietary BiTAC approach is designed to improve the precision of antibody-based cancer therapies by activating therapeutic effects only in targeted tumor cells. The company maintains a diversified oncology pipeline of antibody-based formats including antibody-drug conjugates (“ADCs”), T-cell engagers (“TCEs”), and other antibody-based formats. VERAXA recently began trading on the NASDAQ Capital Market under the…

WednesdayJun 24, 2026 10:30 am

Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF): Cancer Nanomedicine Enters a New Generation

Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) and may include paid advertising. Cancer nanomedicine is emerging from an early period of skepticism, with more than 20 approved formulations now improving therapeutic index and patient quality of life during treatment Onco-Innovations' lead drug candidate, ONC010, pairs a small-molecule PNKP inhibitor with a polymer nanodelivery system designed to extend circulation, increase drug retention in tumor, and improve tolerability Recent manufacturing updates, including kilogram-scale precursor production and a proposed Nanosoft Polymers collaboration, point to a sharpening focus on scalability, reproducibility, and regulatory readiness ahead of first-in-human studies For decades,…

WednesdayJun 24, 2026 9:45 am

Beeline Holdings Inc. (NASDAQ: BLNE) Joins Russell Microcap Index as Digital Mortgage Platform Expands AI and Equity Strategy

Beeline’s AI-enabled underwriting and customer acquisition tools are designed to reduce friction in mortgage approvals, particularly for gig-economy borrowers. Shares of Beeline Holdings, Inc. are set to join the Russell Microcap Index effective June 29, increasing visibility among institutional investors. The company’s first-quarter 2026 revenue more than doubled year over year to $2.7 million, while loan originations rose to $85.6 million. Management is targeting younger real estate investors alongside older homeowners seeking access to home equity without refinancing. The company continues investing in automation and adjacent software capabilities as it pursues a broader housing finance technology strategy. Beeline Holdings (NASDAQ:…

WednesdayJun 24, 2026 9:00 am

Greenland Mines Ltd. (NASDAQ: GRML) Is ‘One to Watch’

Greenland Mines’ flagship Skaergaard Project hosts an NI 43-101 Mineral Resource estimate containing 11.4 million ounces PdEq in the Indicated category and 14.1 million ounces PdEq in the Inferred category. The pending acquisition of the Sarfartoq Project would add an advanced rare earth asset with a historical resource estimate, extensive drilling history and exposure to magnet rare earth elements including neodymium and praseodymium. The company’s relationship with Neo Performance Materials includes an offtake arrangement covering up to 60% of future Sarfartoq production, subject to completion of the acquisition and future project development. Greenland Mines is pursuing a North Atlantic critical…

TuesdayJun 23, 2026 11:15 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Announces Another Infrastructure Milestone Amid Advancements Toward Commissioning of Montauban Project Site

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising. ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, recently received the delivery of a propane-fired tilting furnace at its Montauban Project to support on-site melting and casting of gold and silver into doré bars The furnace will form part of the company’s planned circuit for recovering precious metals from permitted tailings material and is a crucial milestone as the company moves to operationalize the facility ESGold has received – and continues to receive – infrastructure and…

TuesdayJun 23, 2026 10:30 am

The $410 Billion Drug Delivery Revolution: Why Drug Delivery May Be the Next Major Frontier in Oncology Innovation

The rapidly expanding nanomedicine and advanced drug-delivery market is attracting growing attention as pharmaceutical companies seek ways to improve therapeutic performance without relying solely on costly new drug discovery programs. By addressing challenges such as poor bioavailability, inconsistent pharmacokinetics and limited tumor penetration, nanotechnology-based delivery systems may unlock additional value from existing oncology drugs. Oncotelic Therapeutics' Deciparticle(TM) platform and Sapu003 program illustrate how innovative drug delivery approaches could help reshape the future of cancer treatment. The search for new cancer therapies has traditionally focused on discovering entirely new drug candidates. While this approach has produced important breakthroughs, it is also…

TuesdayJun 23, 2026 9:45 am

Greenland Energy Company (NASDAQ: GLND) Advances Jameson Project as Greenland Pursues Greater Economic Self-Sufficiency

GLND is advancing exploration at the Jameson Project, one of Greenland's most prospective yet historically underexplored resource regions The company is focused on unlocking economic opportunities that could support job creation, infrastructure development, and long-term revenue generation These developments align with a broader vision: empowering Greenland's path toward greater economic independence through responsible resource development Greenland Energy (NASDAQ: GLND) is positioning itself at the intersection of one of the Arctic’s most compelling economic opportunities. Through the company’s Jameson Project in East Greenland, it is pursuing resource exploration in an area that has long attracted geological interest but has seen only…

TuesdayJun 23, 2026 9:00 am

7th Clinical Trial Agreements Summit to Address Evolving Contracting Challenges in Clinical Research

Date: August 27, 2026 Venue: Sonesta Philadelphia Rittenhouse Hotel, Philadelphia, PA Professionals and executives from clinical, legal, regulatory, and operational sectors are invited to attend the 7th Clinical Trial Agreements Summit, to be held on Aug. 27-28, 2026, at the Sonesta Philadelphia Rittenhouse Hotel in Philadelphia, Pennsylvania. The event is hosted by Dynamic Global Events (“DGE”), a world leader in curating b2b events for life science companies. The summit aims to guide stakeholders in navigating the complex landscape of clinical trial agreements (“CTAs”), as they adapt to new regulations, technologies, and best practices. Why attend? Industry experts will explore practical…

Site Search

Company Search

Category: News